Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 2/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.38 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.33 |
| ▸ | SOST | Q9BQB4 | 1/20 | 0.32 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.30 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.30 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17004249 | 0.83 | CHRNB2 (0.34) | CHRNB2CHRNA4CHRM2CHRM1CHRNB4 | |
| SCHEMBL17004242 | 0.72 | CHRM2 (0.54) | CHRM2CHRM1 | |
| SCHEMBL17004311 | 0.71 | TRPC3 (0.35) | CHRM2CHRM1 | |
| SCHEMBL17004233 | 0.70 | NAAA (0.32) | CHRM2CHRM1 | |
| SCHEMBL17004295 | 0.69 | CHRNB2 (0.41) | CHRNB2CHRNA4GPR119CHRM1 | |
| SCHEMBL17004243 | 0.69 | S1PR4 (0.33) | CHRNB4CHRNA3 | |
| SCHEMBL17004288 | 0.69 | FLT3 (0.34) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL17004220 | 0.69 | CHRNB2 (0.36) | CHRNB2CHRNA4CHRM2CHRM1CHRNB4 | |
| SCHEMBL23021681 | 0.69 | CHRNB2 (0.47) | CHRNB2CHRNA4GPR119SIRT3TDP1 | |
| SCHEMBL17004285 | 0.69 | HSD11B1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2099795-B1 | AZAADAMANTANE DERIVATIVES AND THEIR USES AS NICOTINIC ACETYLCHOLINE RECEPTORS LIGANDS | ABBVIE BAHAMAS LTD (BS) | 2015-08-19 | — | — | EP | disclosed |